This study investigates how artificial intelligence improves precision medicine in liver cancer by enhancing diagnosis, prognostication, and treatment selection through multimodal data integration, despite translational challenges.
This study investigates combining osimertinib and gefitinib in advanced lung cancer with EGFR C797S mutation, showing modest benefits but highlighting tumor resistance and limited efficacy.
This study investigates the prognostic impact of somatic mutations in mesothelioma, showing NF2 truncating variants worsen survival, supporting genomic testing to guide treatment strategies.
This study investigates the benefits of digital breast tomosynthesis over conventional mammography in older women, showing limited advantage in detecting smaller tumors or invasive lobular carcinoma at age ≥75.